ICCC vs ZS · rev $17.5M vs rev $3.35B
ImmuCell Corporation (ICCC) versus Zscaler Inc (ZS) — a side-by-side from cached financials, not a winner call.
ImmuCell Corporation (ICCC) is a biotechnology company listed on US.
Zscaler Inc (ZS) is a software - infrastructure company listed on US. It is led by Jagtar Singh Chaudhry.
Latest reported ICCC revenue for 2026-06-30 was $17.5M. Net income was $3.8M. Revenue was up 69.4% from 2026-03-31 to 2026-06-30. ICCC currently screens at market cap $58.9M.
Latest reported ZS revenue for 2026-07-31 was $3.35B. Net income was -$63.2M. Revenue was up 25.4% from 2025-07-31 to 2026-07-31. ZS currently screens at market cap $49.01B.
ICCC currently screens at market cap $58.9M. ZS currently screens at market cap $49.01B.
Not investment advice. Open the ICCC and ZS stock pages for the full models.
Not investment advice.